Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Breast density clue for cancer risk (opens in a new tab)

news-medical.net · 2026-09-18

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

  • 3 supported
  • 1 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Three of five check out. One claim the study doesn't address.

  • 3 supported
  • 1 overstated
  • 1 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedWomen with a higher Body Mass Index in early adulthood may have a lower risk of developing breast cancer after the menopause because of lasting changes in the structure of their breast tissue.View evidenceHide evidence

Why this verdict

The paper profile supports an inverse association between BMI at age 20 and post-menopausal breast cancer risk, and a counterfactual mediation estimate suggesting VAS mammographic density may partially mediate that association. However, the headline wording says women may have lower risk 'because of lasting changes' in breast tissue, which frames a causal/mechanistic explanation more strongly than the observational abstract-level evidence can establish. It also omits the 'partial' nature of the mediation; the headline slightly outruns the more cautious body framing.

1

Study evidence

Higher BMI at age 20 was associated with lower post‑menopausal breast cancer risk.HR per 5 kg/m2 = 0.849 (95% CI 0.771–0.938)

“We analysed data from 33,816 post-menopausal women in the UK PROCAS cohort, with self-reported BMI at age 20.”
Claim 2 of 5Not coveredThe findings do not suggest that gaining weight is protective, and the researchers say maintaining a healthy weight remains important because excess weight in later adulthood is linked to a higher risk of breast cancer and many other serious diseases.View evidenceHide evidence

Why this verdict

The supplied abstract profile supports caution that the findings are observational and do not establish that weight gain is protective. However, the specific quoted statement, the recommendation to maintain a healthy weight, and the broader claim that excess later-adulthood weight is linked to higher breast cancer risk and many other serious diseases are not reported in the supplied abstract-level paper profile. Those may be true from external context or full-text/commentary, but they are not verifiable at this evidence depth.

1

Study evidence

Higher BMI at age 20 was associated with lower post‑menopausal breast cancer risk.HR per 5 kg/m2 = 0.849 (95% CI 0.771–0.938)

“We analysed data from 33,816 post-menopausal women in the UK PROCAS cohort, with self-reported BMI at age 20.”
2

Study evidence

Both higher VAS percent density and higher Volpara FGV were associated with increased post‑menopausal breast cancer risk.

“Higher VAS and FGV were associated with increased breast cancer risk.”
Claim 3 of 5SupportedAn analysis of data from more than 33,000 women found that breast density could partially explain the link between a higher body weight at age 20 and a lower chance of post-menopausal breast cancer.View evidenceHide evidence

As statedpartially explain

Why this verdict

The abstract-level profile reports 33,816 post-menopausal women in UK PROCAS, an inverse association between higher BMI at age 20 and breast cancer risk, and a counterfactual mediation result indicating VAS mammographic density may partially explain the association. The wording 'could partially explain' is appropriately hedged and matches the paper's reported mediation framing.

1

Study evidence

Higher BMI at age 20 was associated with lower post‑menopausal breast cancer risk.HR per 5 kg/m2 = 0.849 (95% CI 0.771–0.938)

“We analysed data from 33,816 post-menopausal women in the UK PROCAS cohort, with self-reported BMI at age 20.”
Claim 4 of 5SupportedThe researchers followed 33,816 women in the UK Predicting Risk of Cancer at Screening (PROCAS) program for more than a decade and recorded 1,261 cases of post-menopausal breast cancer.View evidenceHide evidence

As stated33,816 women; 1,261 cases

Why this verdict

The profile states that the study analysed 33,816 post-menopausal women in the UK PROCAS cohort, with median follow-up of 10.44 years and 1,261 incident post-menopausal breast cancers. 'More than a decade' is a fair rendering of the median follow-up.

1

Study evidence

Higher BMI at age 20 was associated with lower post‑menopausal breast cancer risk.HR per 5 kg/m2 = 0.849 (95% CI 0.771–0.938)

“We analysed data from 33,816 post-menopausal women in the UK PROCAS cohort, with self-reported BMI at age 20.”
Claim 5 of 5SupportedFor every five-point increase in BMI at age 20, the risk of developing post-menopausal breast cancer fell by around 15 percent, and lower breast density may account for almost 60 percent of this effect.View evidenceHide evidence

As statedaround 15 percent; almost 60 percent

Why this verdict

The reported HR per 5 kg/m² higher BMI at age 20 was 0.849, which corresponds to about a 15% lower hazard/risk, and the reported proportion mediated by VAS density was 59.9%, i.e. almost 60%. The story's point estimates match the abstract-level profile, though it does not mention the wide confidence interval around the mediation estimate.

1

Study evidence

Higher BMI at age 20 was associated with lower post‑menopausal breast cancer risk.HR per 5 kg/m2 = 0.849 (95% CI 0.771–0.938)

“We analysed data from 33,816 post-menopausal women in the UK PROCAS cohort, with self-reported BMI at age 20.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The mediation estimate was imprecise: the 95% CI for the proportion mediated was 32.6% to 150%, extending beyond 100%.

    The story reports the 'almost 60%' point estimate but does not mention the very wide confidence interval or the resulting uncertainty/model instability around the mediation proportion.

    From prospective cohort mediation analysis (counterfactual natural direct/indirect effects); Prospective cohort association a

  • BMI at age 20 was self-reported, creating potential recall or measurement error.

    The paper profile lists self-reported early-adult BMI as a limitation. The story describes BMI at age 20 but does not mention that it was self-reported.

    From prospective cohort mediation analysis (counterfactual natural direct/indirect effects); Prospective cohort association a

  • Residual confounding and counterfactual mediation assumptions remain limitations of the observational analysis.

    Although the story cautions against interpreting weight gain as protective, its listed caveats do not explicitly mention residual confounding, measurement error, or the assumptions required for counterfactual mediation inference.

    From prospective cohort mediation analysis (counterfactual natural direct/indirect effects); Prospective cohort association a

  • The paper compared two mammographic density metrics, VAS percent density and Volpara-derived fibroglandular volume, and found different patterns for FGV versus VAS density.

    The story discusses breast density generally, but the abstract-level profile identifies a material secondary finding: both VAS and FGV related to risk, while FGV was associated with BMI at cohort entry but not BMI at age 20, suggesting a different pathway.

    From Prospective cohort association and mediation analysis

4 things the story did carry across
  • The study was an observational prospective cohort/mediation analysis, not an intervention showing that changing weight causes lower cancer risk.
  • Higher self-reported BMI at age 20 was associated with lower post-menopausal breast cancer risk, with HR per 5 kg/m² = 0.849.
  • VAS percent mammographic density was estimated to mediate 59.9% of the BMI-at-20 to breast-cancer association after accounting for intermediate confounding by later-adulthood BMI.
  • The results apply to post-menopausal women in the UK PROCAS cohort, with generalizability beyond that cohort or to pre-menopausal breast cancer not addressed in the abstract.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoTest whether mammographic density mediates the inverse association between higher early-adulthood BMI (age 20) and lower post-menopausal breast cancer risk in the UK PROCAS cohort using counterfactual mediation modeling.prospective cohort mediation analysis (counterfactual natural direct/indirect effects)Expand

In plain English

In 33,816 post‑menopausal women from the UK PROCAS cohort, the authors used counterfactual mediation modelling to test whether mammographic density (measured as VAS percent density and Volpara-derived fibroglandular volume) mediates the inverse association between self-reported BMI at age 20 and incident post‑menopausal breast cancer over a median 10.44 years of follow-up. Higher BMI at age 20 was associated with lower VAS density and with reduced breast cancer risk (HR per 5 kg/m2 0.849, 95% CI 0.771–0.938). The estimated proportion of the BMI20 → breast cancer association mediated via VAS density was 59.9% (32.6–150) after accounting for intermediate confounding by later-adulthood BMI; Volpara FGV showed a different pattern, being positively associated with higher BMI at cohort entry but not at age 20.

Key findings

  • Higher BMI at age 20 was associated with lower post‑menopausal breast cancer risk.HR per 5 kg/m2 = 0.849 (95% CI 0.771–0.938)
  • Higher BMI at age 20 was associated with lower VAS percent mammographic density.
“We analysed data from 33,816 post-menopausal women in the UK PROCAS cohort, with self-reported BMI at age 20.”
What this piece can’t prove
  • BMI at age 20 was self‑reported (potential measurement error).
  • Observational cohort design: mediation estimates rely on modelling assumptions and potential for unmeasured confounding.
  • Proportion mediated estimate for VAS has a wide confidence interval that exceeds 100% (32.6–150), indicating imprecision.
  • Abstract does not report full covariate adjustment set or detailed effect estimates for all reported associations.
2human in vivoQuantify and compare associations of two mammographic density metrics (VAS % density and Volpara-derived fibroglandular volume) with post-menopausal breast cancer risk and with early-adulthood BMI.Prospective cohort association and mediation analysisExpand

In plain English

In 33,816 post‑menopausal women from the UK PROCAS cohort (median follow‑up 10.44 years, 1,261 incident breast cancers), the authors compared two mammographic density (MD) metrics — visual analogue scale (VAS) percent density and Volpara® fibroglandular volume (FGV) — for associations with post‑menopausal breast cancer risk and with body mass index (BMI) at age 20 and at cohort entry. Both VAS and FGV were positively associated with breast cancer risk. Higher BMI at age 20 was associated with lower VAS density and with reduced post‑menopausal breast cancer risk (HR per 5 kg/m² 0.849, 95% CI 0.771–0.938). Counterfactual mediation analysis estimated that VAS percent density mediated a substantial portion of the inverse association between BMI at age 20 and post‑menopausal breast cancer risk (proportion mediated 59.9%, 95% CI 32.6–150%) after accounting for intermediate confounding by later‑life BMI. FGV showed a positive association with BMI at cohort entry but not with BMI at age 20, suggesting potentially distinct biological pathways for FGV‑related risk.

Key findings

  • Both higher VAS percent density and higher Volpara FGV were associated with increased post‑menopausal breast cancer risk.
  • Higher BMI at age 20 was associated with lower VAS percent density and with reduced post‑menopausal breast cancer risk.HR per 5 kg/m² = 0.849 (95% CI 0.771–0.938)
“Higher VAS and FGV were associated with increased breast cancer risk.”
What this piece can’t prove
  • BMI at age 20 was self‑reported (possible recall bias).
  • Abstract lacks detailed numeric effect estimates for VAS and FGV associations with breast cancer risk and with contemporaneous BMI.
  • Proportion mediated estimate is imprecise (CI extends beyond 100%), indicating uncertainty in mediation quantification.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 15 candidate papers

Candidate

Body mass index, mammographic density and post-menopausal breast cancer risk: a mediation analysis v1

2025 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.